These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 10774581

  • 1. [CPT-11: new drug for metastatic colorectal cancer].
    Barone C, Pozzo C, Cassano A.
    Tumori; 1999; 85(6):A1-11. PubMed ID: 10774581
    [No Abstract] [Full Text] [Related]

  • 2. Irinotecan for metastatic colorectal cancer.
    Med Lett Drugs Ther; 1997 Jan 17; 39(992):8. PubMed ID: 9008684
    [No Abstract] [Full Text] [Related]

  • 3. [Standard therapy of CPT-11 for colorectal cancer].
    Saitoh S, Sakata Y.
    Gan To Kagaku Ryoho; 2001 Oct 17; 28(10):1345-51. PubMed ID: 11681240
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Irinotecan. A review of its pharmacological properties and clinical efficacy in the management of advanced colorectal cancer.
    Wiseman LR, Markham A.
    Drugs; 1996 Oct 17; 52(4):606-23. PubMed ID: 8891470
    [Abstract] [Full Text] [Related]

  • 6. Irinotecan in the treatment of colorectal cancer: clinical overview.
    Vanhoefer U, Harstrick A, Achterrath W, Cao S, Seeber S, Rustum YM.
    J Clin Oncol; 2001 Mar 01; 19(5):1501-18. PubMed ID: 11230497
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Chemotherapy: Optimizing irinotecan regimens for colorectal cancer.
    Yim KL, Cunningham D.
    Nat Rev Clin Oncol; 2009 Oct 01; 6(10):560-1. PubMed ID: 19786997
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical trials of irinotecan hydrochloride (CPT, campto injection, topotecin injection) in Japan.
    Saijo N.
    Ann N Y Acad Sci; 1996 Dec 13; 803():292-305. PubMed ID: 8993523
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations.
    Cerea G, Vaghi M, Ardizzoia A, Villa S, Bucovec R, Mengo S, Gardani G, Tancini G, Lissoni P.
    Anticancer Res; 2003 Dec 13; 23(2C):1951-4. PubMed ID: 12820485
    [Abstract] [Full Text] [Related]

  • 15. [Application and recent research progress of irinotecan in treatment of advanced colorectal cancer].
    Guan ZZ.
    Zhonghua Zhong Liu Za Zhi; 2006 Sep 13; 28(9):718-9. PubMed ID: 17274384
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A rapid and systematic review of the evidence for the clinical effectiveness and cost-effectiveness of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer.
    Lloyd Jones M, Hummel S, Bansback N, Orr B, Seymour M.
    Health Technol Assess; 2001 Sep 13; 5(25):1-128. PubMed ID: 11990245
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.